Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders

Drug and Alcohol Review

Volumn 29, Issue 5, 2010, Pages 518-524

  Baillie, Andrew J ^a   Stapinski, Lexine ^a   Crome, Erica ^a   Morley, Kirsten ^b   Sannibale, Claudia ^b,c   Haber, Paul ^b   Teesson, Maree ^c  

^a MACQUARIE UNIVERSITY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety disorder; Comorbidity; Substance use disorder

Indexed keywords

ADDICTION; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; METHODOLOGY; PSYCHIATRIC DIAGNOSIS; PSYCHOTHERAPY; TREATMENT OUTCOME;

ANXIETY DISORDERS; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; PSYCHOTHERAPY; RESEARCH DESIGN; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 77957902901     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2010.00206.x     Document Type: Article

References (61)

1. Morris EP, Stewart SH, Ham LS. The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clin Psychol Rev 2005;25:734-60.
2. Merikangas KR, Mehta RL, Molnar BE, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addict Behav 1998;23:893-907.
3. Oei TPS, Loveday WA. Management of co-morbid anxiety and alcohol disorders: parallel treatment of disorders. Drug Alcohol Rev 1997;16:261-74.
4. Schade A, Marquenie L, van Balkom A, et al. The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcohol Clin Exp Res 2005;29:794-800.
5. Randall C, Thomas S, Thevos A. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res 2001;25:210-20.
6. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970;23:455-68.
7. Klein DN, Riso LP. Psychiatric disorders: problems of boundaries and comorbidity. In: Costello CG, ed. Basic issues in psychopathology. New York: Guilford, 1994:19-66.
8. Neale MC, Kendler KS. Models of comorbidity for multifactorial disorders. Am J Hum Genet 1995;57:935-53.
9. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics Bull 1947;2:47-53.
10. Hall W, Degenhardt L, Teesson M. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base. Addict Behav 2009;34:526-30.
11. Grant MD, Lyons MJ, Lehman CL, et al. Elucidating the comorbid relationship between panic disorder and alcohol dependence in Vietnam era male twins. Am J Med Genet B Neuropsychiatr Genet 2005;138B:35.
12. Kendler KS. Introduction to a proposal for a meta-structure for DSM-V and ICD-11. Psychol Med 2009;39:1991.
13. Krueger RF, Markon KE. Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annu Rev Clin Psychol 2006;2:111-33.
14. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 1994;151:1723-34.
15. Sclafani VD, Finn P, Fein G. Psychiatric comorbidity in long-term abstinent alcoholic individuals. Alcohol Clin Exp Res 2007;31:795-803.
16. Haslam N. Categorical versus dimensional models of mental disorder: the taxometric evidence. Aust N Z J Psychiatry 2003;37:696-704.
17. Meehl PE. Bootstraps taxometrics: solving the classification problem in psychopathology. Am Psychol 1995;50:266-75.
18. Widiger TA, Samuel, DB. Diagnostic categories or dimension? A question for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition. J Abnorm Psychol 2005;114:494-504.
19. Proudfoot H, Baillie AJ, Teesson M. The structure of alcohol dependence in the Australian community. Drug Alcohol Depend 2006;81:21-6.
20. Sunderland M, Mewton L, Slade T, Baillie AJ. Investigating differential symptom profiles in major depressive episode with and without generalized anxiety disorder: true co-morbidity or symptom similarity? Psychol Med 2009; Doi: http://dx.doi.org/10.1017/S0033291709991590.
21. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-21.
22. Kushner MG, Krueger RF, Frye B, Peterson J. Epidemiological perspectives on co-occuring anxiety disorder and substance use disorder. In: Stewart SH, Conrod PJ, eds. Anxiety and substance use disorders: the vicious cycle of comorbidity. NewYork: Springer, 2008:3-17.
23. Buckner JD, Turner RJ. Social anxiety disorder as a risk factor for alcohol use disorders: a prospective examination of parental and peer influences. Drug Alcohol Depend 2009;100:128-37.
24. McEvoy PM, Shand F. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders. J Anxiety Disord 2008;22:1087-98.
25. Schade A, Marquenie LA, van Balkom AJ, et al. Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence. Eur Addict Res 2007;13:109-15.
26. Subotic M, Baillie AJ, Stapinski L, et al. Does the level of alcohol consumption at pre-treatment mediate treatment efficacy. 39th Annual Congress of European Association for Behavioural and Cognitive Therapies; 19th September 2009; Dubrovnik, Croatia.
27. Burns L, Teesson M, O'Neill K. The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction 2005;100:787-96.
28. Dingle GA, King P. Prevalence and impact of co-occurring psychiatric disorders on outcomes from a private hospital drug and alcohol treatment program. Ment Health Subst Use 2009;2:13-23.
29. Marquenie LA, Schade A, Van Balkom A, et al. Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study. Alcohol Alcohol 2006;41:168-73.
30. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001;158:848-56.
31. Baillie A, Sannibale C. Anxiety and drug and alcohol problems. In: Baker A, Velleman R, eds. Clinical handbook of co-existing mental health and drug and alcohol problems. London: Brunner-Routledge, 2007:195-214.
32. Fals-Stewart W, Schafer J. The treatment of substance abusers diagnosed with obsessive-compulsive disorder: an outcome study. J Subst Abuse Treat 1992;9:365-70.
33. Ormrod J, Budd R. A comparison of two treatment interventions aimed at lowering anxiety levels and alcohol consumption amongst alcohol abusers. Drug Alcohol Depend 1991;27:233-43.
34. Bowen RC, D'Arcy C, Keegan D, Senthilselvan A. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav 2000;25:593-7.
35. Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with Panic Disorder. Am J Psychiatry 1993;150:1485-90.
36. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res 2001;25: 210-20.
37. Toneatto T. Cognitive versus behavioral treatment of concurrent alcohol dependence and agoraphobia: a pilot study. Addict Behav 2005;30:115-25.
38. Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 2009;9:8.
39. Montori VM, Wilczynski NL, Morgan D, Haynes RB, for the Hedges Team. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. BMJ 2005;330:68-76.
40. Najavits LM, Harned MS, Gallop RJ, et al. Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial. J Stud Alcohol Drugs 2007;68:353-61.
41. Najavits LM, Gallop RJ, Weiss RD. Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial. J Behav Health Serv Res 2006;33:453-63.
42. Najavits LM, Schmitz M, Gotthardt S, Weiss RD. Seeking safety plus exposure therapy: an outcome study on dual diagnosis men. J Psychoactive Drugs 2005;37:425-35.
43. Back SE, Brady KT, Sonne SC, Verduin ML. Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis 2006;194:690-6.
44. Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res 2005;29:395-401.
45. Stewart SH, Conrod PJ. Anxiety disorder and substance use disorder co-morbidity: common themes and future directions. In: Stewart SH, Conrod PJ, eds. Anxiety and substance use disorders: the vicious cycle of comorbidity. New York: Springer, 2008:239-57.
46. Stewart SH, Kushner MG. Introduction to the special issues on 'Anxiety sensitivity and addictive behaviors'. Addict Behav 2001;26:775-85.
47. Stewart SH, Samoluk SB, MacDonald AB. Anxiety sensitivity and substance use and abuse. In: Taylor S, ed. Anxiety sensitivity: theory, research, and treatment of the fear of anxiety. Mahwah: Lawrence Erlbaum Associates Publishers, 1999:287-319.
48. Tull MT, Schulzinger D, Schmidt NB, Zvolensky MJ, Lejuez CW. Development and initial examination of a brief intervention for heightened anxiety sensitivity among heroin users. Behav Modif 2007;31:220-42.
49. Conrod PJ, Stewart SH, Comeau N, Maclean AM. Efficacy of cognitive-behavioral interventions targeting personality risk factors for youth alcohol misuse. J Clin Child Adolesc Psychol 2006;35:550-63.
50. Kushner MG, Sletten S, Donahue C, et al. Cognitivebehavioral therapy for panic disorder in patients being treated for alcohol dependence: moderating effects of alcohol outcome expectancies. Addict Behav 2009;34:554-60.
51. Kushner MG, Donahue C, Sletten S, et al. Cognitive behavioral treatment of comorbid anxiety disorder in alcoholism treatment patients: presentation of a prototype program and future directions. J Ment Health 2006;15:697-707.
52. Goldman MS, Brown SA, Christiansen BA. Expectancy theory: thinking about drinking. In: Blane HT, Leonard KE, eds. Psychological theories of drinking and alcoholism. NewYork: Guilford Press, 1987:181-226.
53. Thomas SE, Randall PK, Book SW, Randall CL. A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res 2008;32:77-84.
54. Book SW, Thomas SE, Randall PK, Randall CL. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. J Anxiety Disord 2008;22:310-18.
55. Malat J, Leszcz M, Negrete JC, et al. Interpersonal group psychotherapy for comorbid alcohol dependence and nonpsychotic psychiatric disorders. Am J Addict 2008;17: 402-7.
56. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, NewYork State Psychiatric Institute, 2002.
57. Brown TA, DiNardo P, Barlow DH. Anxiety disorder interview schedule. NewYork: Oxford, 2004.
58. Spitzer RL. Psychiatric diagnosis: are clinicians still necessary? Compr Psychiatry 1983;24:399-411.
59. Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? Compr Psychiatry 1995;36:278-88.
60. Kushner MG, Kenneth JS, Erickson DJ. Prospective analysis of the relation betwen DSM III anxiety disorders and alcohol use disorder. Am J Psychiatry 1999;156:723-32.
61. Zimmermann P, Wittchen HU, Hofler M, Pfister H, Kessler RC, Lieb R. Primary anxiety disorders and the development of subsequent alcohol use disorder: a 4-year community study of adolescents and young adults. Psychol Med 2003;33:1211-22.